BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35637051)

  • 21. Functional characterization of an IgE-class monoclonal antibody specific for the bullous pemphigoid autoantigen, BP180.
    Messingham KA; Onoh A; Vanderah EM; Giudice GJ; Fairley JA
    Hybridoma (Larchmt); 2012 Apr; 31(2):111-7. PubMed ID: 22509915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain.
    Kromminga A; Sitaru C; Meyer J; Arndt R; Schmidt E; Christophers E; Bröcker EB; Zillikens D
    J Dermatol Sci; 2002 Jan; 28(1):68-75. PubMed ID: 11916132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid.
    Messingham KA; Noe MH; Chapman MA; Giudice GJ; Fairley JA
    J Immunol Methods; 2009 Jul; 346(1-2):18-25. PubMed ID: 19422829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay.
    Fairley JA; Bream M; Fullenkamp C; Syrbu S; Chen M; Messingham KN
    J Am Acad Dermatol; 2013 Mar; 68(3):395-403. PubMed ID: 23083837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.
    Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ
    J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of IgG and IgE reactivity to BP180 using the ISAC® microarray system.
    Pomponi D; Di Zenzo G; Zennaro D; Calabresi V; Eming R; Zuzzi S; Bernardi ML; Scala E; Mari A
    Br J Dermatol; 2013 Jun; 168(6):1205-14. PubMed ID: 23252883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins.
    Nakatani C; Muramatsu T; Shirai T
    Br J Dermatol; 1998 Sep; 139(3):365-70. PubMed ID: 9767278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
    Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T
    Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
    Allen J; Shears E; Powell J; Wojnarowska F
    Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses.
    Laffitte E; Skaria M; Jaunin F; Tamm K; Saurat JH; Favre B; Borradori L
    Br J Dermatol; 2001 Apr; 144(4):760-8. PubMed ID: 11298534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
    Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
    J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
    Mariotti F; Grosso F; Terracina M; Ruffelli M; Cordiali-Fei P; Sera F; Zambruno G; Mastrogiacomo A; Di Zenzo G
    Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid.
    Hashimoto T; Ohzono A; Teye K; Numata S; Hiroyasu S; Tsuruta D; Hachiya T; Kuroda K; Hashiguchi M; Kawakami T; Ishii N
    Br J Dermatol; 2017 Jul; 177(1):141-151. PubMed ID: 27716903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230).
    Ghohestani RF; Cozzani E; Delaporte E; Nicolas JF; Parodi A; Claudy A
    J Clin Immunol; 1998 May; 18(3):202-9. PubMed ID: 9624579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses.
    Fania L; Caldarola G; Müller R; Brandt O; Pellicano R; Feliciani C; Hertl M
    Clin Immunol; 2012 Jun; 143(3):236-45. PubMed ID: 22534318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in Germans.
    Schwarm C; Gola D; Holtsche MM; Dieterich A; Bhandari A; Freitag M; Nürnberg P; Toliat M; Lieb W; Wittig M; Franke A; Worm M; Sticherling M; Ehrchen J; Günther C; Gläser R; Peitsch WK; Sárdy M; Eming R; Hertl M; Benoit S; Goebeler M; Pföhler C; Kunz M; Kreuter A; van Beek N; Erdmann J; Busch H; Zillikens D; Sadik CD; Hirose M; König IR; Schmidt E; Ibrahim SM;
    Orphanet J Rare Dis; 2021 May; 16(1):228. PubMed ID: 34011352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid.
    Sadik CD; Langan EA; Grätz V; Zillikens D; Terheyden P
    Front Immunol; 2019; 10():1934. PubMed ID: 31474998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.
    Zillikens D
    Keio J Med; 2002 Mar; 51(1):21-8. PubMed ID: 11951375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score.
    Holtsche MM; Goletz S; van Beek N; Zillikens D; Benoit S; Harman K; Walton S; English J; Sticherling M; Chapman A; Levell NJ; Groves R; Williams HC; König IR; Schmidt E;
    Br J Dermatol; 2018 Oct; 179(4):918-924. PubMed ID: 29607480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.